XM_040170600.1	chrIII	9857629	9857629	chrIII	9852069	9859300	-	XM_040170600.1	path1	A7YWD2	Importin-13		 PF03810;PF18773;PF18786;PF18806;PF08389;	 GO:0005737;GO:0005634;GO:0031267;GO:0006606;	  C:cytoplasm; C:nucleus;	  F:small GTPase binding;	  P:protein import into nucleus;
XM_040170609.1	chrIII	9896309	9896309	chrIII	9890825	9900399	+	XM_040170609.1	path1	O95841 Q5T5Z5	Angiopoietin-related protein 1	Angiopoietin-3;Angiopoietin-like protein 1;	 PF00147;	 GO:0062023;GO:0070062;GO:0005615;GO:0005102;GO:0001525;GO:0007169;	  C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular space;	  F:signaling receptor binding;	  P:angiogenesis; P:transmembrane receptor protein tyrosine kinase signaling pathway;
XM_040170621.1	chrIII	9899275	9899275	chrIII	9902701	9906735	+	XM_040170621.1	path1	Q6NWA8	Transcriptional adapter 1	Transcriptional adapter 1-like protein;	 PF12767;	 GO:0000124;GO:0003713;GO:0006357;	  C:SAGA complex;	  F:transcription coactivator activity;	  P:regulation of transcription by RNA polymerase II;
XM_040170623.1	chrIII	9901486	9901486	chrIII	9907142	9909294	-	XM_040170623.1	path1	P12981	Transcription factor AP-1	Proto-oncogene c-Jun;	 PF00170;PF03957;	 GO:0005634;GO:0003700;GO:0000976;GO:0007265;	  C:nucleus;	  F:DNA-binding transcription factor activity; F:transcription regulatory region sequence-specific DNA binding;	  P:Ras protein signal transduction;
XM_040173612.1	chrIV	16454292	16454292	chrIV	16452382	16459867	+	XM_040173612.1	path1	Q63HQ0 B2RCV7 Q96GG6 Q9H0V0 Q9P1L4	AP-1 complex-associated regulatory protein	2c18;Adaptor-related protein complex 1-associated regulatory protein;Gamma-1-adaptin brefeldin A resistance protein;Gamma-A1-adaptin and kinesin interactor;	 PF15745;	 GO:0005829;GO:0005769;GO:0005768;GO:0005794;GO:0005770;GO:0030133;GO:0035650;GO:0019894;GO:0034613;GO:2000146;GO:0001920;GO:1900025;GO:0015031;GO:0034315;GO:0048203;	  C:cytosol; C:early endosome; C:endosome; C:Golgi apparatus; C:late endosome; C:transport vesicle;	  F:AP-1 adaptor complex binding; F:kinesin binding;	  P:cellular protein localization; P:negative regulation of cell motility; P:negative regulation of receptor recycling; P:negative regulation of substrate adhesion-dependent cell spreading; P:protein transport; P:regulation of Arp2/3 complex-mediated actin nucleation; P:vesicle targeting, trans-Golgi to endosome;
XM_040173606.1	chrIV	16458395	16458395	chrIV	16460623	16468883	+	XM_040173606.1	path1	Q9W7E7	Mothers against decapentaplegic homolog 5	Protein somitabun;SMAD family member 5;	 PF03165;PF03166;	 GO:0005737;GO:0071144;GO:0003700;GO:0000981;GO:0070411;GO:0046872;GO:0000978;GO:0000976;GO:0009653;GO:0048514;GO:0030509;GO:0030154;GO:0007368;GO:0048264;GO:0060030;GO:0009953;GO:0003143;GO:0009880;GO:0001947;GO:0001945;GO:0043049;GO:0060037;GO:0045893;GO:0036342;GO:0048922;GO:0048919;GO:2000223;GO:0006355;GO:0060021;GO:0060395;GO:0007179;	  C:cytoplasm; C:heteromeric SMAD protein complex;	  F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:I-SMAD binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;	  P:anatomical structure morphogenesis; P:blood vessel morphogenesis; P:BMP signaling pathway; P:cell differentiation; P:determination of left/right symmetry; P:determination of ventral identity; P:dorsal convergence; P:dorsal/ventral pattern formation; P:embryonic heart tube morphogenesis; P:embryonic pattern specification; P:heart looping; P:lymph vessel development; P:otic placode formation; P:pharyngeal system development; P:positive regulation of transcription, DNA-templated; P:post-anal tail morphogenesis; P:posterior lateral line neuromast deposition; P:posterior lateral line neuromast development; P:regulation of BMP signaling pathway involved in heart jogging; P:regulation of transcription, DNA-templated; P:roof of mouth development; P:SMAD protein signal transduction; P:transforming growth factor beta receptor signaling pathway;
XM_040174066.1	chrIV	16620660	16620660	chrIV	16570205	16691246	-	XM_040174066.1	path1	O55112 B1ATW0	AF4/FMR2 family member 2	FMR2P;Fragile X mental retardation protein 2 homolog;Protein Ox19;	 PF18876;PF18875;	 GO:0016607;GO:0005634;GO:0002151;GO:0007611;GO:0006397;GO:0010629;GO:0035063;GO:0010468;GO:0043484;GO:0008380;	  C:nuclear speck; C:nucleus;	  F:G-quadruplex RNA binding;	  P:learning or memory; P:mRNA processing; P:negative regulation of gene expression; P:nuclear speck organization; P:regulation of gene expression; P:regulation of RNA splicing; P:RNA splicing;
XM_040186993.1	chrIX	996475	996475	chrIX	989250	991503	-	XM_040186993.1	path1	A0A087WSX0	Immunoglobulin lambda variable 5-45 {ECO:0000303|PubMed:11872955, ECO:0000303|Ref.3}		 PF07686;	 GO:0005615;GO:0019814;GO:0005886;GO:0002250;GO:0006955;	  C:extracellular space; C:immunoglobulin complex; C:plasma membrane;	 	  P:adaptive immune response; P:immune response;
XM_040185633.1	chrIX	14971874	14971874	chrIX	14928350	15016395	-	XM_040185633.1	path1	Q6P1Y8	Type II inositol 3,4-bisphosphate 4-phosphatase	Inositol polyphosphate 4-phosphatase type II;	 	 GO:0005737;GO:0017161;GO:0052828;GO:0008289;GO:0034593;GO:0034594;GO:0016316;GO:0034597;GO:0006874;GO:0046855;GO:0045671;GO:0046856;GO:0046850;GO:0046822;GO:0051896;	  C:cytoplasm;	  F:inositol-1,3,4-trisphosphate 4-phosphatase activity; F:inositol-3,4-bisphosphate 4-phosphatase activity; F:lipid binding; F:phosphatidylinositol bisphosphate phosphatase activity; F:phosphatidylinositol trisphosphate phosphatase activity; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity;	  P:cellular calcium ion homeostasis; P:inositol phosphate dephosphorylation; P:negative regulation of osteoclast differentiation; P:phosphatidylinositol dephosphorylation; P:regulation of bone remodeling; P:regulation of nucleocytoplasmic transport; P:regulation of protein kinase B signaling;
XM_040187380.1	chrIX	16853094	16853094	chrIX	16816974	16834611	+	XM_040187380.1	path1	Q3ULZ2 B9EHC4 Q69ZC2 Q8C0A0	FH2 domain-containing protein 1	Inverted formin-1 {ECO:0000303|PubMed:18815276};	 PF02181;	 GO:0005929;GO:0005881;GO:0005794;GO:0005874;GO:0003779;GO:0008017;GO:0060271;GO:0090161;GO:0043149;	  C:cilium; C:cytoplasmic microtubule; C:Golgi apparatus; C:microtubule;	  F:actin binding; F:microtubule binding;	  P:cilium assembly; P:Golgi ribbon formation; P:stress fiber assembly;
XM_040186447.1	chrIX	16853094	16853094	chrIX	16838566	16854817	+	XM_040186447.1	path1	Q9C040 D3DP09 O60272 Q9BSI9 Q9UFZ1	Tripartite motif-containing protein 2	E3 ubiquitin-protein ligase TRIM2;RING finger protein 86;RING-type E3 ubiquitin transferase TRIM2 {ECO:0000305};	 PF00630;PF01436;PF00643;PF13445;	 GO:0005737;GO:0061630;GO:0004842;GO:0008270;GO:0043161;GO:0000209;GO:0043523;	  C:cytoplasm;	  F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;	  P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of neuron apoptotic process;
XM_040186449.1	chrIX	16853094	16853094	chrIX	16855267	16863845	+	XM_040186449.1	path1	Q8K396 Q9D0A1	Meiotic nuclear division protein 1 homolog		 PF18517;PF03962;	 GO:0005634;GO:0003690;GO:0007131;	  C:nucleus;	  F:double-stranded DNA binding;	  P:reciprocal meiotic recombination;
XM_040186080.1	chrIX	16853094	16853094	chrIX	16866670	16889472	+	XM_040186080.1	path1	A2VDJ0 B3KRV3 D3DP10 Q7LGA7 Q86Y92 Q8WU56 Q9H065 Q9Y2D7	Transmembrane protein 131-like {ECO:0000312|HGNC:HGNC:29146}		 PF12371;	 GO:0005737;GO:0005783;GO:0016021;GO:0016020;GO:0005886;GO:0090090;GO:0033088;GO:0016055;	  C:cytoplasm; C:endoplasmic reticulum; C:integral component of membrane; C:membrane; C:plasma membrane;	 	  P:negative regulation of canonical Wnt signaling pathway; P:negative regulation of immature T cell proliferation in thymus; P:Wnt signaling pathway;
XM_040175806.1	chrV	14370920	14370920	chrV	14351712	14356331	-	XM_040175806.1	path1	Q4R8E0	Eukaryotic translation initiation factor 2-alpha kinase 1 {ECO:0000305}	Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase {ECO:0000250|UniProtKB:Q9BQI3};Hemin-sensitive initiation factor 2-alpha kinase {ECO:0000250|UniProtKB:Q9BQI3};	 PF00069;	 GO:0005737;GO:0005524;GO:0004694;GO:0106310;GO:0106311;GO:0140468;GO:0140467;GO:0017148;	  C:cytoplasm;	  F:ATP binding; F:eukaryotic translation initiation factor 2alpha kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;	  P:HRI-mediated signaling; P:integrated stress response signaling; P:negative regulation of translation;
XM_040175802.1	chrV	14370920	14370920	chrV	14357170	14361926	+	XM_040175802.1	path1	F1NQJ3 Q5ZJ94	Mismatch repair endonuclease PMS2 {ECO:0000305}	DNA mismatch repair protein PMS2 {ECO:0000305};PMS1 protein homolog 2 {ECO:0000250|UniProtKB:P54278};	 PF01119;PF08676;	 GO:0036464;GO:0005829;GO:0032300;GO:0032389;GO:0005654;GO:0005886;GO:0005524;GO:0016887;GO:0004519;GO:0032407;GO:0032138;GO:0003697;GO:0006298;GO:0007095;GO:0030890;GO:0016446;	  C:cytoplasmic ribonucleoprotein granule; C:cytosol; C:mismatch repair complex; C:MutLalpha complex; C:nucleoplasm; C:plasma membrane;	  F:ATP binding; F:ATPase activity; F:endonuclease activity; F:MutSalpha complex binding; F:single base insertion or deletion binding; F:single-stranded DNA binding;	  P:mismatch repair; P:mitotic G2 DNA damage checkpoint; P:positive regulation of B cell proliferation; P:somatic hypermutation of immunoglobulin genes;
XM_040175799.1	chrV	14370920	14370920	chrV	14366377	14371906	-	XM_040175799.1	path1	Q8K4R9 Q6ZQL3 Q80VS7 Q8BUC8 Q8BZ79	Disks large-associated protein 5	Discs large homolog 7;Disks large-associated protein DLG7;Hepatoma up-regulated protein homolog;	 PF03359;	 GO:0034451;GO:0005737;GO:0005829;GO:0005739;GO:0005634;GO:0031616;GO:0008017;GO:0051642;GO:0007059;GO:0051382;GO:0007052;GO:0007346;GO:0023052;	  C:centriolar satellite; C:cytoplasm; C:cytosol; C:mitochondrion; C:nucleus; C:spindle pole centrosome;	  F:microtubule binding;	  P:centrosome localization; P:chromosome segregation; P:kinetochore assembly; P:mitotic spindle organization; P:regulation of mitotic cell cycle; P:signaling;
XM_040175811.1	chrV	14370920	14370920	chrV	14372118	14378894	-	XM_040175811.1	path1	Q4S4I5	Vacuolar fusion protein CCZ1 homolog		 PF19031;PF19032;PF19033;	 GO:0005765;GO:0035658;GO:0016192;	  C:lysosomal membrane; C:Mon1-Ccz1 complex;	 	  P:vesicle-mediated transport;
XR_005712247.1	chrV	14397560	14397560	chrV	14393880	14396156	+	XR_005712247.1	path1	Q96Q04 Q4G0U1	Serine/threonine-protein kinase LMTK3	Lemur tyrosine kinase 3;	 PF07714;	 GO:0030424;GO:0030425;GO:0000139;GO:0016021;GO:0005524;GO:0046872;GO:0004672;GO:0106310;GO:0106311;GO:0010923;GO:0006468;	  C:axon; C:dendrite; C:Golgi membrane; C:integral component of membrane;	  F:ATP binding; F:metal ion binding; F:protein kinase activity; F:protein serine kinase activity; F:protein threonine kinase activity;	  P:negative regulation of phosphatase activity; P:protein phosphorylation;
XM_040176594.1	chrV	14397560	14397560	chrV	14393891	14396156	+	XM_040176594.1	path1	Q8IWU2 A4D272 Q75MG7 Q9UPS3	Serine/threonine-protein kinase LMTK2	Apoptosis-associated tyrosine kinase 2;Brain-enriched kinase;CDK5/p35-regulated kinase;Kinase/phosphatase/inhibitor 2;Lemur tyrosine kinase 2;Serine/threonine-protein kinase KPI-2;	 PF07714;	 GO:0005829;GO:0005769;GO:0005794;GO:0030426;GO:0016021;GO:0005887;GO:0043025;GO:0048471;GO:0043235;GO:0055037;GO:0005524;GO:0070853;GO:0004864;GO:0106310;GO:0004674;GO:0106311;GO:0007409;GO:0045022;GO:0032456;GO:0007275;GO:0018105;GO:0018107;GO:0018108;GO:0033674;GO:0046777;GO:0006468;GO:0001881;GO:0033572;GO:0007169;	  C:cytosol; C:early endosome; C:Golgi apparatus; C:growth cone; C:integral component of membrane; C:integral component of plasma membrane; C:neuronal cell body; C:perinuclear region of cytoplasm; C:receptor complex; C:recycling endosome;	  F:ATP binding; F:myosin VI binding; F:protein phosphatase inhibitor activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;	  P:axonogenesis; P:early endosome to late endosome transport; P:endocytic recycling; P:multicellular organism development; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:peptidyl-tyrosine phosphorylation; P:positive regulation of kinase activity; P:protein autophosphorylation; P:protein phosphorylation; P:receptor recycling; P:transferrin transport; P:transmembrane receptor protein tyrosine kinase signaling pathway;
XM_040176591.1	chrV	14397560	14397560	chrV	14396753	14399798	+	XM_040176591.1	path1	Q7RTS1 A4D271 Q14DE4	Class A basic helix-loop-helix protein 15	Class B basic helix-loop-helix protein 8;Muscle, intestine and stomach expression 1;	 PF00010;	 GO:0000785;GO:0005634;GO:0001228;GO:0000981;GO:0042802;GO:0046983;GO:0000978;GO:1990837;GO:0019722;GO:0048469;GO:0007267;GO:0042149;GO:0030968;GO:0007186;GO:0042593;GO:0007030;GO:0048312;GO:0006851;GO:0010832;GO:0030182;GO:0006357;	  C:chromatin; C:nucleus;	  F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:identical protein binding; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:calcium-mediated signaling; P:cell maturation; P:cell-cell signaling; P:cellular response to glucose starvation; P:endoplasmic reticulum unfolded protein response; P:G protein-coupled receptor signaling pathway; P:glucose homeostasis; P:Golgi organization; P:intracellular distribution of mitochondria; P:mitochondrial calcium ion transmembrane transport; P:negative regulation of myotube differentiation; P:neuron differentiation; P:regulation of transcription by RNA polymerase II;
XM_040176590.1	chrV	14397560	14397560	chrV	14399771	14408397	-	XM_040176590.1	path1	E1BZR9	Tectonin beta-propeller repeat-containing protein 1		 PF06462;PF06398;PF19193;	 GO:0000421;GO:0031410;GO:0016021;GO:0005765;GO:0032266;GO:0097352;GO:0006914;	  C:autophagosome membrane; C:cytoplasmic vesicle; C:integral component of membrane; C:lysosomal membrane;	  F:phosphatidylinositol-3-phosphate binding;	  P:autophagosome maturation; P:autophagy;
XM_040177338.1	chrV	14397560	14397560	chrV	14408939	14423843	-	XM_040177338.1	path1	Q9DBJ3	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1	Insulin receptor tyrosine kinase substrate;	 PF08397;PF14604;	 GO:0015629;GO:0005829;GO:0005654;GO:0005886;GO:0003779;GO:0070064;GO:0051764;GO:0051017;GO:0007009;GO:2000251;GO:0030838;GO:0046626;GO:0009617;	  C:actin cytoskeleton; C:cytosol; C:nucleoplasm; C:plasma membrane;	  F:actin binding; F:proline-rich region binding;	  P:actin crosslink formation; P:actin filament bundle assembly; P:plasma membrane organization; P:positive regulation of actin cytoskeleton reorganization; P:positive regulation of actin filament polymerization; P:regulation of insulin receptor signaling pathway; P:response to bacterium;
XM_040176851.1	chrV	14554185	14554185	chrV	14519374	14542113	+	XM_040176851.1	path1	Q5MJS3 Q4FJP0 Q571A3 Q6PKA8 Q8JZP7	Extracellular serine/threonine protein kinase FAM20C {ECO:0000305}	Dentin matrix protein 4 {ECO:0000303|PubMed:17369251};Golgi-enriched fraction casein kinase {ECO:0000250|UniProtKB:Q8IXL6};	 PF06702;	 GO:0005737;GO:0005615;GO:0005794;GO:0005524;GO:0005509;GO:0030145;GO:0016773;GO:0106310;GO:0004674;GO:0106311;GO:0046034;GO:0031214;GO:0097187;GO:0070166;GO:0071895;GO:0036179;GO:0030501;GO:0045669;GO:0006468;GO:0040036;GO:0051174;GO:0001501;	  C:cytoplasm; C:extracellular space; C:Golgi apparatus;	  F:ATP binding; F:calcium ion binding; F:manganese ion binding; F:phosphotransferase activity, alcohol group as acceptor; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;	  P:ATP metabolic process; P:biomineral tissue development; P:dentinogenesis; P:enamel mineralization; P:odontoblast differentiation; P:osteoclast maturation; P:positive regulation of bone mineralization; P:positive regulation of osteoblast differentiation; P:protein phosphorylation; P:regulation of fibroblast growth factor receptor signaling pathway; P:regulation of phosphorus metabolic process; P:skeletal system development;
XM_040176356.1	chrV	14554185	14554185	chrV	14544714	14548942	+	XM_040176356.1	path1	A0A1W2PRP0	Forkhead box protein L3 {ECO:0000305}		 PF00250;	 GO:0005634;GO:0000981;GO:0000978;GO:0009653;GO:0030154;GO:0006357;	  C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;	  P:anatomical structure morphogenesis; P:cell differentiation; P:regulation of transcription by RNA polymerase II;
XM_040176353.1	chrV	14554185	14554185	chrV	14552557	14559671	-	XM_040176353.1	path1	Q5SRX1 A0JP66 Q5SRX7 Q5SRY0 Q6P5D7 Q8C6J0 Q8C935 Q8CB51 Q8R4H1	TOM1-like protein 2	Target of Myb-like protein 2;	 PF03127;PF00790;	 GO:0005768;GO:0016020;GO:0030276;GO:0019901;GO:0006886;GO:0045839;GO:0007165;	  C:endosome; C:membrane;	  F:clathrin binding; F:protein kinase binding;	  P:intracellular protein transport; P:negative regulation of mitotic nuclear division; P:signal transduction;
XM_040176355.1	chrV	14554185	14554185	chrV	14559863	14562496	-	XM_040176355.1	path1	Q91YY4 Q8BP08	ATP synthase mitochondrial F1 complex assembly factor 2		 PF07542;	 GO:0005829;GO:0005739;GO:0016607;GO:0043461;	  C:cytosol; C:mitochondrion; C:nuclear speck;	 	  P:proton-transporting ATP synthase complex assembly;
XM_040176357.1	chrV	14554185	14554185	chrV	14562721	14566283	+	XM_040176357.1	path1	Q9CPY6 Q3TP79 Q7TT31 Q99JE9	Glucose-induced degradation protein 4 homolog	Vacuolar import and degradation protein 24 homolog;	 PF09783;	 GO:0000151;GO:0061630;GO:0043161;	  C:ubiquitin ligase complex;	  F:ubiquitin protein ligase activity;	  P:proteasome-mediated ubiquitin-dependent protein catabolic process;
XM_040175708.1	chrV	14554185	14554185	chrV	14570749	14573952	+	XM_040175708.1	path1	Q8NFA2 Q86YM1 Q8NFA3 Q96B73	NADPH oxidase organizer 1	NADPH oxidase regulatory protein;Nox organizer 1;Nox-organizing protein 1;SH3 and PX domain-containing protein 5;	 PF14604;	 GO:0005737;GO:0043020;GO:0005886;GO:0019899;GO:0060090;GO:0035091;GO:0005543;GO:0016176;GO:0022617;GO:0031343;GO:0010310;GO:0060263;GO:0006801;	  C:cytoplasm; C:NADPH oxidase complex; C:plasma membrane;	  F:enzyme binding; F:molecular adaptor activity; F:phosphatidylinositol binding; F:phospholipid binding; F:superoxide-generating NADPH oxidase activator activity;	  P:extracellular matrix disassembly; P:positive regulation of cell killing; P:regulation of hydrogen peroxide metabolic process; P:regulation of respiratory burst; P:superoxide metabolic process;
XM_040182318.1	chrVII	571487	571487	chrVII	565513	571420	+	XM_040182318.1	path1	Q9C040 D3DP09 O60272 Q9BSI9 Q9UFZ1	Tripartite motif-containing protein 2	E3 ubiquitin-protein ligase TRIM2;RING finger protein 86;RING-type E3 ubiquitin transferase TRIM2 {ECO:0000305};	 PF00630;PF01436;PF00643;PF13445;	 GO:0005737;GO:0061630;GO:0004842;GO:0008270;GO:0043161;GO:0000209;GO:0043523;	  C:cytoplasm;	  F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity; F:zinc ion binding;	  P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein polyubiquitination; P:regulation of neuron apoptotic process;
XM_040183084.1	chrVII	571487	571487	chrVII	572263	576414	-	XM_040183084.1	path1	P86810 F8S6K5	L-amino-acid oxidase {ECO:0000303|PubMed:21333741}	Antiparasitic protein {ECO:0000303|PubMed:20117218};Serum L-amino-acid oxidase;	 PF01593;	 GO:0005576;GO:0001716;GO:0042742;GO:0045087;	  C:extracellular region;	  F:L-amino-acid oxidase activity;	  P:defense response to bacterium; P:innate immune response;
XM_040180580.1	chrVII	681839	681839	chrVII	680305	691103	-	XM_040180580.1	path1	Q505K2 Q8BZ23	FHF complex subunit HOOK interacting protein 1A {ECO:0000305}		 PF10257;	 GO:1905719;	 	 	  P:protein localization to perinuclear region of cytoplasm;
XM_040180586.1	chrVII	686309	686309	chrVII	687773	703756	+	XM_040180586.1	path1	Q5HYK7 B7Z296 Q08EK1 Q32N10 Q5U3B8 Q86XB3 Q8N5E7 Q9UFC8	SH3 domain-containing protein 19	ADAM-binding protein Eve-1;EEN-binding protein;	 PF00018;PF07653;PF14604;	 GO:0005829;GO:0005654;GO:0005886;GO:0070064;GO:0007010;GO:0051044;GO:0006892;GO:0022604;	  C:cytosol; C:nucleoplasm; C:plasma membrane;	  F:proline-rich region binding;	  P:cytoskeleton organization; P:positive regulation of membrane protein ectodomain proteolysis; P:post-Golgi vesicle-mediated transport; P:regulation of cell morphogenesis;
XM_040183204.1	chrVII	754363	754363	chrVII	750055	757375	+	XM_040183204.1	path1	Q66S03	Galactose-specific lectin nattectin		 PF00059;	 GO:0005576;GO:0030246;GO:0046872;GO:0090729;GO:0006954;	  C:extracellular region;	  F:carbohydrate binding; F:metal ion binding; F:toxin activity;	  P:inflammatory response;
XM_040183197.1	chrVII	754363	754363	chrVII	757474	765904	+	XM_040183197.1	path1	Q80V23 Q3UIS3	Zinc finger protein 32	Zinc finger protein 637;	 PF00096;	 GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;	  C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:regulation of transcription by RNA polymerase II;
XM_040183987.1	chrVIII	1940966	1940966	chrVIII	1917323	1969384	+	XM_040183987.1	path1	Q9C0H5 B4E1I1	Rho GTPase-activating protein 39		 PF00784;PF00620;	 GO:0005737;GO:0005856;GO:0005829;GO:0098978;GO:0005634;GO:0005096;GO:0099173;GO:0051056;GO:0007165;	  C:cytoplasm; C:cytoskeleton; C:cytosol; C:glutamatergic synapse; C:nucleus;	  F:GTPase activator activity;	  P:postsynapse organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction;
XM_040183852.1	chrVIII	2227484	2227484	chrVIII	2146656	2276541	+	XM_040183852.1	path1	Q02780 P70250 P70251 Q3UUZ2 Q61960 Q8VBT5 Q9R1G5	Nuclear factor 1 A-type	CCAAT-box-binding transcription factor;Nuclear factor I/A;TGGCA-binding protein;	 PF00859;PF03165;PF10524;	 GO:0030054;GO:0005654;GO:0005634;GO:0003682;GO:0003677;GO:0001228;GO:0000981;GO:0000978;GO:0008134;GO:0006260;GO:0045944;GO:0045893;GO:0006357;GO:0060074;GO:0072189;	  C:cell junction; C:nucleoplasm; C:nucleus;	  F:chromatin binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription factor binding;	  P:DNA replication; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:synapse maturation; P:ureter development;
XM_040183929.1	chrVIII	2344374	2344374	chrVIII	2291728	2378080	+	XM_040183929.1	path1	F1MAD2	InaD-like protein {ECO:0000250|UniProtKB:Q8NI35}	Channel-interacting PDZ domain-containing protein {ECO:0000250|UniProtKB:Q63ZW7};Pals1-associated tight junction protein {ECO:0000250|UniProtKB:Q63ZW7};Protein associated to tight junctions {ECO:0000250|UniProtKB:Q8NI35};	 PF09045;PF00595;	 GO:0045177;GO:0016324;GO:0005923;GO:0048471;GO:0032991;GO:0070160;GO:0035089;GO:0120192;	  C:apical part of cell; C:apical plasma membrane; C:bicellular tight junction; C:perinuclear region of cytoplasm; C:protein-containing complex; C:tight junction;	 	  P:establishment of apical/basal cell polarity; P:tight junction assembly;
XM_040185242.1	chrVIII	11390203	11390203	chrVIII	11317270	11506768	+	XM_040185242.1	path1	Q13332 O75255 O75870 Q15718 Q16341 Q2M3R7	Receptor-type tyrosine-protein phosphatase S	Receptor-type tyrosine-protein phosphatase sigma;	 PF00041;PF07679;PF00102;	 GO:0030424;GO:0005829;GO:0070062;GO:0098978;GO:0030426;GO:0005887;GO:0099061;GO:0099056;GO:0030285;GO:0043204;GO:0005886;GO:0098685;GO:0035374;GO:0043395;GO:0008201;GO:0004721;GO:0004725;GO:0021549;GO:0021987;GO:0022038;GO:0090557;GO:0021766;GO:0050804;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0032687;GO:0032688;GO:0010977;GO:0034164;GO:0035335;GO:0006470;GO:0099151;GO:0021510;GO:0099560;	  C:axon; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane; C:Schaffer collateral - CA1 synapse;	  F:chondroitin sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;	  P:cerebellum development; P:cerebral cortex development; P:corpus callosum development; P:establishment of endothelial intestinal barrier; P:hippocampus development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of neuron projection development; P:negative regulation of toll-like receptor 9 signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of postsynaptic density assembly; P:spinal cord development; P:synaptic membrane adhesion;
XM_040184116.1	chrVIII	11537455	11537455	chrVIII	11517332	11526797	+	XM_040184116.1	path1	Q95125 Q95124	Thromboxane A2 receptor	Prostanoid TP receptor;	 PF00001;	 GO:0016021;GO:0016607;GO:0005886;GO:0004961;GO:0007189;GO:0006954;GO:0090051;GO:0045777;GO:0007204;GO:0045987;GO:0045907;GO:0032496;GO:0019932;	  C:integral component of membrane; C:nuclear speck; C:plasma membrane;	  F:thromboxane A2 receptor activity;	  P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of blood pressure; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of smooth muscle contraction; P:positive regulation of vasoconstriction; P:response to lipopolysaccharide; P:second-messenger-mediated signaling;
XM_040183968.1	chrVIII	18952193	18952193	chrVIII	18943470	18951869	+	XM_040183968.1	path1	Q90805	Cyclic nucleotide-gated channel cone photoreceptor subunit alpha	CNG channel 1;	 PF16526;PF00027;PF00520;	 GO:0016021;GO:0030552;GO:0030553;GO:0005222;GO:0005223;GO:0050896;GO:0007601;	  C:integral component of membrane;	  F:cAMP binding; F:cGMP binding; F:intracellular cAMP-activated cation channel activity; F:intracellular cGMP-activated cation channel activity;	  P:response to stimulus; P:visual perception;
XM_040183971.1	chrVIII	18952193	18952193	chrVIII	18943474	18951869	+	XM_040183971.1	path1	Q16281 E9PF93 Q4VAP7 Q53RD2 Q6ZNA7 Q9UP64	Cyclic nucleotide-gated cation channel alpha-3	Cone photoreceptor cGMP-gated channel subunit alpha;Cyclic nucleotide-gated channel alpha-3;	 PF16526;PF00027;PF00520;	 GO:0043194;GO:0005737;GO:0030425;GO:0097386;GO:0043204;GO:0005886;GO:1902495;GO:0030553;GO:0005222;GO:0005223;GO:0015276;GO:0008022;GO:0006812;GO:0098659;GO:0051591;GO:0031960;GO:0032026;GO:0007165;GO:0007601;	  C:axon initial segment; C:cytoplasm; C:dendrite; C:glial cell projection; C:perikaryon; C:plasma membrane; C:transmembrane transporter complex;	  F:cGMP binding; F:intracellular cAMP-activated cation channel activity; F:intracellular cGMP-activated cation channel activity; F:ligand-gated ion channel activity; F:protein C-terminus binding;	  P:cation transport; P:inorganic cation import across plasma membrane; P:response to cAMP; P:response to corticosteroid; P:response to magnesium ion; P:signal transduction; P:visual perception;
XM_040183967.1	chrVIII	18952193	18952193	chrVIII	18952660	18960463	-	XM_040183967.1	path1	Q05086 A8K8Z9 P78355 Q93066 Q9UEP4 Q9UEP5 Q9UEP6 Q9UEP7 Q9UEP8 Q9UEP9	Ubiquitin-protein ligase E3A	E6AP ubiquitin-protein ligase {ECO:0000303|PubMed:17108031};HECT-type ubiquitin transferase E3A;Human papillomavirus E6-associated protein {ECO:0000303|PubMed:8380895};Oncogenic protein-associated protein E6-AP {ECO:0000303|PubMed:8380895};Renal carcinoma antigen NY-REN-54;	 PF16558;PF00632;	 GO:0005829;GO:0005634;GO:0000502;GO:0046872;GO:0003713;GO:0061630;GO:0004842;GO:0030521;GO:0007420;GO:1990416;GO:0061002;GO:0001541;GO:1905528;GO:0014068;GO:0031398;GO:0045944;GO:0050847;GO:0060736;GO:0051865;GO:0070936;GO:0006508;GO:0042752;GO:2000058;GO:0042220;GO:0042542;GO:0032570;GO:0048511;GO:0035037;GO:0006511;GO:0016032;	  C:cytosol; C:nucleus; C:proteasome complex;	  F:metal ion binding; F:transcription coactivator activity; F:ubiquitin protein ligase activity; F:ubiquitin-protein transferase activity;	  P:androgen receptor signaling pathway; P:brain development; P:cellular response to brain-derived neurotrophic factor stimulus; P:negative regulation of dendritic spine morphogenesis; P:ovarian follicle development; P:positive regulation of Golgi lumen acidification; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of protein ubiquitination; P:positive regulation of transcription by RNA polymerase II; P:progesterone receptor signaling pathway; P:prostate gland growth; P:protein autoubiquitination; P:protein K48-linked ubiquitination; P:proteolysis; P:regulation of circadian rhythm; P:regulation of ubiquitin-dependent protein catabolic process; P:response to cocaine; P:response to hydrogen peroxide; P:response to progesterone; P:rhythmic process; P:sperm entry; P:ubiquitin-dependent protein catabolic process; P:viral process;
XM_040183966.1	chrVIII	18952193	18952193	chrVIII	18964569	18985318	-	XM_040183966.1	path1	O54827 Q8R3B8	Phospholipid-transporting ATPase VA	ATPase class V type 10A;P-locus fat-associated ATPase;P4-ATPase flippase complex alpha subunit ATP10A;	 PF16212;PF16209;	 GO:0005783;GO:0005789;GO:0005887;GO:1990531;GO:0005886;GO:0005524;GO:0140326;GO:0140351;GO:0000287;GO:0140345;GO:0045332;GO:1903527;	  C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of plasma membrane; C:phospholipid-translocating ATPase complex; C:plasma membrane;	  F:ATP binding; F:ATPase-coupled intramembrane lipid transporter activity; F:glycosylceramide flippase activity; F:magnesium ion binding; F:phosphatidylcholine flippase activity;	  P:phospholipid translocation; P:positive regulation of membrane tubulation;
XM_040183839.1	chrVIII	18991858	18991858	chrVIII	18995459	19014545	-	XM_040183839.1	path1	P19019	Gamma-aminobutyric acid receptor subunit beta-3	GABA(A) receptor subunit beta-3;	 PF02931;PF02932;	 GO:0034707;GO:0030659;GO:1902711;GO:0005887;GO:0043005;GO:0005886;GO:0045211;GO:0045202;GO:0004890;GO:0022851;GO:0030594;GO:0007268;GO:1902476;GO:0007214;GO:1904862;GO:0034220;GO:0050877;GO:0042391;GO:0007165;	  C:chloride channel complex; C:cytoplasmic vesicle membrane; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynaptic membrane; C:synapse;	  F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:neurotransmitter receptor activity;	  P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:inhibitory synapse assembly; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:signal transduction;
XM_040183840.1	chrVIII	19009987	19009987	chrVIII	19015350	19027643	+	XM_040183840.1	path1	P31644 A8K338 Q14DC2 Q53XL6 Q9NYT3 Q9NYT4 Q9NYT5	Gamma-aminobutyric acid receptor subunit alpha-5	GABA(A) receptor subunit alpha-5;	 PF02931;PF02932;	 GO:0034707;GO:0005829;GO:0032590;GO:1902711;GO:0098982;GO:0005887;GO:0099060;GO:0099056;GO:0043005;GO:0032809;GO:0005654;GO:0005886;GO:0098794;GO:0045202;GO:0050811;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:0038023;GO:1904315;GO:0005215;GO:0008306;GO:0001662;GO:0007420;GO:0007268;GO:1902476;GO:0090102;GO:0007214;GO:0060119;GO:0060384;GO:0034220;GO:0043524;GO:0050877;GO:0042391;GO:0060078;GO:0007605;GO:0007165;GO:0051932;	  C:chloride channel complex; C:cytosol; C:dendrite membrane; C:GABA-A receptor complex; C:GABA-ergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic specialization membrane; C:integral component of presynaptic membrane; C:neuron projection; C:neuronal cell body membrane; C:nucleoplasm; C:plasma membrane; C:postsynapse; C:synapse;	  F:GABA receptor binding; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; F:transporter activity;	  P:associative learning; P:behavioral fear response; P:brain development; P:chemical synaptic transmission; P:chloride transmembrane transport; P:cochlea development; P:gamma-aminobutyric acid signaling pathway; P:inner ear receptor cell development; P:innervation; P:ion transmembrane transport; P:negative regulation of neuron apoptotic process; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:sensory perception of sound; P:signal transduction; P:synaptic transmission, GABAergic;
XM_040183417.1	chrVIII	19132297	19132297	chrVIII	19096404	19134721	-	XM_040183417.1	path1	O95714 Q86SV7 Q86SV8 Q86SV9 Q86YY3 Q86YY4 Q86YY5 Q86YY6 Q86YY7 Q86YY8 Q86YY9 Q86YZ0 Q86YZ1	E3 ubiquitin-protein ligase HERC2	HECT domain and RCC1-like domain-containing protein 2;HECT-type E3 ubiquitin transferase HERC2;	 PF03256;PF11515;PF00173;PF00632;PF06701;PF00415;PF00569;	 GO:0005814;GO:0005737;GO:0005829;GO:0016020;GO:0005654;GO:0005634;GO:0005886;GO:0005085;GO:0032183;GO:0061630;GO:0031625;GO:0008270;GO:0006974;GO:0006302;GO:0006303;GO:0006886;GO:0016567;	  C:centriole; C:cytoplasm; C:cytosol; C:membrane; C:nucleoplasm; C:nucleus; C:plasma membrane;	  F:guanyl-nucleotide exchange factor activity; F:SUMO binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:zinc ion binding;	  P:cellular response to DNA damage stimulus; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:intracellular protein transport; P:protein ubiquitination;
XM_040183429.1	chrVIII	19132297	19132297	chrVIII	19133869	19137887	+	XM_040183429.1	path1	Q8BHK1	Magnesium transporter NIPA1	Non-imprinted in Prader-Willi/Angelman syndrome region protein 1 homolog;	 PF05653;	 GO:0005769;GO:0016021;GO:0016020;GO:0005886;GO:0015095;GO:0015693;	  C:early endosome; C:integral component of membrane; C:membrane; C:plasma membrane;	  F:magnesium ion transmembrane transporter activity;	  P:magnesium ion transport;
XM_040183418.1	chrVIII	19132297	19132297	chrVIII	19142711	19162888	-	XM_040183418.1	path1	Q90YM8 Q58ES3	Cytoplasmic FMR1-interacting protein 1 homolog		 PF07159;PF05994;	 GO:0005737;GO:0030027;GO:0043005;GO:0048471;GO:0001726;GO:0031209;GO:0045202;GO:0051015;GO:0000340;GO:0031267;GO:0048675;GO:0007411;GO:0000902;GO:0030031;GO:0030032;GO:0099563;GO:0030833;GO:0008360;GO:0006417;GO:0031529;	  C:cytoplasm; C:lamellipodium; C:neuron projection; C:perinuclear region of cytoplasm; C:ruffle; C:SCAR complex; C:synapse;	  F:actin filament binding; F:RNA 7-methylguanosine cap binding; F:small GTPase binding;	  P:axon extension; P:axon guidance; P:cell morphogenesis; P:cell projection assembly; P:lamellipodium assembly; P:modification of synaptic structure; P:regulation of actin filament polymerization; P:regulation of cell shape; P:regulation of translation; P:ruffle organization;
XM_040183419.1	chrVIII	19185093	19185093	chrVIII	19163602	19171149	-	XM_040183419.1	path1	Q96RT8 E9PB12 Q6IQ52 Q96PY8	Gamma-tubulin complex component 5		 PF04130;PF17681;	 GO:0005813;GO:0005829;GO:0000923;GO:0000930;GO:0008274;GO:0005874;GO:0000922;GO:0043015;GO:0008017;GO:0031122;GO:0051321;GO:0007020;GO:0000278;GO:0051225;	  C:centrosome; C:cytosol; C:equatorial microtubule organizing center; C:gamma-tubulin complex; C:gamma-tubulin ring complex; C:microtubule; C:spindle pole;	  F:gamma-tubulin binding; F:microtubule binding;	  P:cytoplasmic microtubule organization; P:meiotic cell cycle; P:microtubule nucleation; P:mitotic cell cycle; P:spindle assembly;
XM_040183424.1	chrVIII	19185093	19185093	chrVIII	19171695	19174643	+	XM_040183424.1	path1	Q9EP78 Q99NB0	Carbohydrate sulfotransferase 7	Chondroitin 6-sulfotransferase 2;Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5;N-acetylglucosamine 6-O-sulfotransferase 4;	 PF00685;	 GO:0000139;GO:0016021;GO:0005802;GO:0008459;GO:0001517;GO:0005975;GO:0030206;GO:0006044;GO:0006790;	  C:Golgi membrane; C:integral component of membrane; C:trans-Golgi network;	  F:chondroitin 6-sulfotransferase activity; F:N-acetylglucosamine 6-O-sulfotransferase activity;	  P:carbohydrate metabolic process; P:chondroitin sulfate biosynthetic process; P:N-acetylglucosamine metabolic process; P:sulfur compound metabolic process;
XM_040183423.1	chrVIII	19185093	19185093	chrVIII	19174805	19191028	-	XM_040183423.1	path1	Q8BLV3 A2ACD5 A2ACD6	Sodium/hydrogen exchanger 7	Na(+)/H(+) exchanger 7;Solute carrier family 9 member 7;	 PF00999;	 GO:0016021;GO:0043231;GO:0005886;GO:0055037;GO:0055038;GO:0005802;GO:0015386;GO:0015385;GO:0071805;GO:1905526;GO:0051453;GO:0006885;GO:0098719;	  C:integral component of membrane; C:intracellular membrane-bounded organelle; C:plasma membrane; C:recycling endosome; C:recycling endosome membrane; C:trans-Golgi network;	  F:potassium:proton antiporter activity; F:sodium:proton antiporter activity;	  P:potassium ion transmembrane transport; P:regulation of Golgi lumen acidification; P:regulation of intracellular pH; P:regulation of pH; P:sodium ion import across plasma membrane;
XM_040183425.1	chrVIII	19185093	19185093	chrVIII	19192418	19197954	+	XM_040183425.1	path1	F1QC45 F1D694 Q802Z6	Protein XRP2 {ECO:0000250|UniProtKB:O75695}		 PF00334;PF07986;	 GO:0005929;GO:1990075;GO:0005525;GO:0005096;GO:0000902;GO:0061371;GO:0001947;GO:0042461;GO:0045494;GO:0035845;GO:0006892;GO:0048793;GO:0015031;GO:0060041;GO:0010842;	  C:cilium; C:periciliary membrane compartment;	  F:GTP binding; F:GTPase activator activity;	  P:cell morphogenesis; P:determination of heart left/right asymmetry; P:heart looping; P:photoreceptor cell development; P:photoreceptor cell maintenance; P:photoreceptor cell outer segment organization; P:post-Golgi vesicle-mediated transport; P:pronephros development; P:protein transport; P:retina development in camera-type eye; P:retina layer formation;
XM_040183421.1	chrVIII	19185093	19185093	chrVIII	19198974	19205385	+	XM_040183421.1	path1	Q7ZVP1	Protein Jade-3	Jade family PHD finger protein 3;PHD finger protein 16;	 PF10513;	 GO:0000123;GO:0046872;GO:0043966;GO:0043981;GO:0043982;	  C:histone acetyltransferase complex;	  F:metal ion binding;	  P:histone H3 acetylation; P:histone H4-K5 acetylation; P:histone H4-K8 acetylation;
XM_040183632.1	chrVIII	19185093	19185093	chrVIII	19207245	19213170	+	XM_040183632.1	path1	Q9NUJ7 A2BH51 A2BH52	PI-PLC X domain-containing protein 1		 PF00388;	 GO:0005737;GO:0008081;GO:0006629;	  C:cytoplasm;	  F:phosphoric diester hydrolase activity;	  P:lipid metabolic process;
XR_005713313.1	chrX	13324823	13324823	chrX	13320692	13321589	-	XR_005713313.1	path1	P14272	Plasma kallikrein	Fletcher factor;Kininogenin;Plasma prekallikrein;	 PF00024;PF00089;	 GO:0005615;GO:0004252;GO:0007596;GO:0042730;GO:0006954;GO:0097421;GO:0031639;GO:0051919;	  C:extracellular space;	  F:serine-type endopeptidase activity;	  P:blood coagulation; P:fibrinolysis; P:inflammatory response; P:liver regeneration; P:plasminogen activation; P:positive regulation of fibrinolysis;
XM_040189752.1	chrX	13324653	13324653	chrX	13326423	13331380	-	XM_040189752.1	path1	Q5NTB3	Coagulation factor XI	Plasma thromboplastin antecedent;	 PF00024;PF00089;	 GO:0005576;GO:0008201;GO:0004252;GO:0007596;	  C:extracellular region;	  F:heparin binding; F:serine-type endopeptidase activity;	  P:blood coagulation;
XM_040188578.1	chrX	13468159	13468159	chrX	13455338	13496486	-	XM_040188578.1	path1	A2BH40 Q640Q1 Q925Q1	AT-rich interactive domain-containing protein 1A	BRG1-associated factor 250;BRG1-associated factor 250a;Osa homolog 1;SWI-like protein;SWI/SNF complex protein p270;SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1;	 PF01388;PF12031;	 GO:0035060;GO:0000785;GO:0071565;GO:0071564;GO:0005654;GO:0016514;GO:0003677;GO:0016922;GO:0030521;GO:0043044;GO:0003205;GO:0055007;GO:0006325;GO:0006338;GO:0007566;GO:0030900;GO:0001704;GO:0007369;GO:0042921;GO:0070829;GO:0030520;GO:0000122;GO:0001843;GO:0006337;GO:0003408;GO:0060674;GO:0045893;GO:0006357;GO:0019827;GO:1901998;	  C:brahma complex; C:chromatin; C:nBAF complex; C:npBAF complex; C:nucleoplasm; C:SWI/SNF complex;	  F:DNA binding; F:nuclear receptor binding;	  P:androgen receptor signaling pathway; P:ATP-dependent chromatin remodeling; P:cardiac chamber development; P:cardiac muscle cell differentiation; P:chromatin organization; P:chromatin remodeling; P:embryo implantation; P:forebrain development; P:formation of primary germ layer; P:gastrulation; P:glucocorticoid receptor signaling pathway; P:heterochromatin maintenance; P:intracellular estrogen receptor signaling pathway; P:negative regulation of transcription by RNA polymerase II; P:neural tube closure; P:nucleosome disassembly; P:optic cup formation involved in camera-type eye development; P:placenta blood vessel development; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II; P:stem cell population maintenance; P:toxin transport;
XM_040193427.1	chrXII	16140847	16140847	chrXII	16035260	16190309	-	XM_040193427.1	path1	Q9UIW2	Plexin-A1	Semaphorin receptor NOV;	 PF08337;PF01437;PF01403;PF01833;PF18020;PF17960;	 GO:0005829;GO:0070062;GO:0005887;GO:0005654;GO:0005886;GO:0002116;GO:0017154;GO:0038023;GO:0060666;GO:0007275;GO:0007162;GO:1990138;GO:0050772;GO:0030334;GO:0008360;GO:0043087;GO:0014910;GO:1902287;	  C:cytosol; C:extracellular exosome; C:integral component of plasma membrane; C:nucleoplasm; C:plasma membrane; C:semaphorin receptor complex;	  F:semaphorin receptor activity; F:signaling receptor activity;	  P:dichotomous subdivision of terminal units involved in salivary gland branching; P:multicellular organism development; P:negative regulation of cell adhesion; P:neuron projection extension; P:positive regulation of axonogenesis; P:regulation of cell migration; P:regulation of cell shape; P:regulation of GTPase activity; P:regulation of smooth muscle cell migration; P:semaphorin-plexin signaling pathway involved in axon guidance;
XM_040193507.1	chrXII	16257591	16257591	chrXII	16251146	16300342	-	XM_040193507.1	path1	Q63ZW2	MICOS complex subunit mic25a	Coiled-coil-helix-coiled-coil-helix domain-containing protein 6;	 	 GO:0061617;GO:0005743;GO:0005739;GO:0006974;GO:0042407;GO:0007007;	  C:MICOS complex; C:mitochondrial inner membrane; C:mitochondrion;	 	  P:cellular response to DNA damage stimulus; P:cristae formation; P:inner mitochondrial membrane organization;
XM_040196053.1	chrXIII	2944819	2944819	chrXIII	2944369	2955873	-	XM_040196053.1	path1	Q9H9H4	Vacuolar protein sorting-associated protein 37B	ESCRT-I complex subunit VPS37B;	 PF07200;	 GO:0005737;GO:0005768;GO:0010008;GO:0000813;GO:0070062;GO:0043657;GO:0043231;GO:0031902;GO:0030496;GO:0005886;GO:0048306;GO:0016197;GO:0075733;GO:0016236;GO:0036258;GO:1903774;GO:1902188;GO:0006612;GO:0006623;GO:0043162;GO:0039702;GO:0019058;	  C:cytoplasm; C:endosome; C:endosome membrane; C:ESCRT I complex; C:extracellular exosome; C:host cell; C:intracellular membrane-bounded organelle; C:late endosome membrane; C:midbody; C:plasma membrane;	  F:calcium-dependent protein binding;	  P:endosomal transport; P:intracellular transport of virus; P:macroautophagy; P:multivesicular body assembly; P:positive regulation of viral budding via host ESCRT complex; P:positive regulation of viral release from host cell; P:protein targeting to membrane; P:protein targeting to vacuole; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:viral budding via host ESCRT complex; P:viral life cycle;
XM_040196047.1	chrXIII	2987171	2987171	chrXIII	2982210	2993299	+	XM_040196047.1	path1	Q12933 A8K107 B4DPJ7 Q7Z337 Q96NT2	TNF receptor-associated factor 2	E3 ubiquitin-protein ligase TRAF2;RING-type E3 ubiquitin transferase TRAF2 {ECO:0000305};Tumor necrosis factor type 2 receptor-associated protein 3;	 PF16673;PF00097;PF02176;	 GO:0035631;GO:0005938;GO:0009898;GO:0005829;GO:1990604;GO:0045121;GO:0005654;GO:0097057;GO:0002947;GO:0000151;GO:0012506;GO:0005174;GO:0019899;GO:0042802;GO:0031435;GO:0019901;GO:0019903;GO:0044877;GO:0030674;GO:0046625;GO:0031996;GO:0043120;GO:0005164;GO:0031625;GO:0004842;GO:0008270;GO:0006919;GO:0007250;GO:0034622;GO:0071732;GO:0071550;GO:0007249;GO:0097400;GO:0070059;GO:0048255;GO:1902042;GO:0034351;GO:1901215;GO:0051091;GO:2001238;GO:0043123;GO:1903721;GO:0032743;GO:0046330;GO:0043507;GO:0051092;GO:0002726;GO:1903265;GO:0097300;GO:0051865;GO:0030163;GO:0016579;GO:0070534;GO:0065003;GO:0042981;GO:1902041;GO:0043122;GO:0002637;GO:0043254;GO:0010803;GO:0034976;GO:0007165;GO:0023019;GO:0033209;	  C:CD40 receptor complex; C:cell cortex; C:cytoplasmic side of plasma membrane; C:cytosol; C:IRE1-TRAF2-ASK1 complex; C:membrane raft; C:nucleoplasm; C:TRAF2-GSTP1 complex; C:tumor necrosis factor receptor superfamily complex; C:ubiquitin ligase complex; C:vesicle membrane;	  F:CD40 receptor binding; F:enzyme binding; F:identical protein binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein kinase binding; F:protein phosphatase binding; F:protein-containing complex binding; F:protein-macromolecule adaptor activity; F:sphingolipid binding; F:thioesterase binding; F:tumor necrosis factor binding; F:tumor necrosis factor receptor binding; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;	  P:activation of cysteine-type endopeptidase activity involved in apoptotic process; P:activation of NF-kappaB-inducing kinase activity; P:cellular protein-containing complex assembly; P:cellular response to nitric oxide; P:death-inducing signaling complex assembly; P:I-kappaB kinase/NF-kappaB signaling; P:interleukin-17-mediated signaling pathway; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; P:mRNA stabilization; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of glial cell apoptotic process; P:negative regulation of neuron death; P:positive regulation of DNA-binding transcription factor activity; P:positive regulation of extrinsic apoptotic signaling pathway; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of I-kappaB phosphorylation; P:positive regulation of interleukin-2 production; P:positive regulation of JNK cascade; P:positive regulation of JUN kinase activity; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of T cell cytokine production; P:positive regulation of tumor necrosis factor-mediated signaling pathway; P:programmed necrotic cell death; P:protein autoubiquitination; P:protein catabolic process; P:protein deubiquitination; P:protein K63-linked ubiquitination; P:protein-containing complex assembly; P:regulation of apoptotic process; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:regulation of I-kappaB kinase/NF-kappaB signaling; P:regulation of immunoglobulin production; P:regulation of protein-containing complex assembly; P:regulation of tumor necrosis factor-mediated signaling pathway; P:response to endoplasmic reticulum stress; P:signal transduction; P:signal transduction involved in regulation of gene expression; P:tumor necrosis factor-mediated signaling pathway;
XM_040195741.1	chrXIII	11085100	11085100	chrXIII	10977247	11103396	-	XM_040195741.1	path1	Q7T297	Cotranscriptional regulator FAM172A homolog {ECO:0000250|UniProtKB:Q3TNH5}	Protein FAM172A;	 	 GO:0005737;GO:0005634;GO:0031048;GO:0006397;GO:0000381;GO:0008380;	  C:cytoplasm; C:nucleus;	 	  P:heterochromatin assembly by small RNA; P:mRNA processing; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing;
XM_040196267.1	chrXIII	17462283	17462283	chrXIII	17437873	17440325	-	XM_040196267.1	path1	Q16559 A0AVI7	T-cell acute lymphocytic leukemia protein 2	Class A basic helix-loop-helix protein 19;	 PF00010;	 GO:0000785;GO:0003677;GO:0000981;GO:0046983;GO:0000978;GO:0030901;GO:0035264;GO:0009791;GO:0006357;GO:0021794;	  C:chromatin;	  F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;	  P:midbrain development; P:multicellular organism growth; P:post-embryonic development; P:regulation of transcription by RNA polymerase II; P:thalamus development;
XR_005714011.1	chrXIII	17460631	17460631	chrXIII	17440620	17446255	+	XR_005714011.1	path1	Q5VXU9 A2A2V3 Q2M1H8 Q96M73	Protein shortage in chiasmata 1 ortholog {ECO:0000305}	Protein ZIP2 homolog {ECO:0000250|UniProtKB:A2ALV5};	 PF17825;	 GO:0005694;GO:0000794;GO:0016887;GO:0003697;GO:0007131;GO:0000712;	  C:chromosome; C:condensed nuclear chromosome;	  F:ATPase activity; F:single-stranded DNA binding;	  P:reciprocal meiotic recombination; P:resolution of meiotic recombination intermediates;
XM_040196671.1	chrXIII	17460631	17460631	chrXIII	17453233	17461950	-	XM_040196671.1	path1	Q7RTR2 Q5EY36 Q8NF48 Q8NI01 Q8NI02 Q8TEL3	NLR family CARD domain-containing protein 3	CARD15-like protein;Caterpiller protein 16.2 {ECO:0000303|PubMed:15705585};NACHT, LRR and CARD domains-containing protein 3;Nucleotide-binding oligomerization domain protein 3;	 PF13516;PF05729;PF17776;PF17779;	 GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0048471;GO:0005524;GO:0036312;GO:0007249;GO:0035556;GO:1900016;GO:0050680;GO:0048147;GO:0043124;GO:0050728;GO:0045824;GO:0032687;GO:0032688;GO:0032715;GO:0032088;GO:1901223;GO:1900226;GO:0014067;GO:0032720;GO:0042110;	  C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm;	  F:ATP binding; F:phosphatidylinositol 3-kinase regulatory subunit binding;	  P:I-kappaB kinase/NF-kappaB signaling; P:intracellular signal transduction; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of epithelial cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-6 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of tumor necrosis factor production; P:T cell activation;
XM_040196622.1	chrXIII	17460631	17460631	chrXIII	17479518	17484965	-	XM_040196622.1	path1	Q9R1R0 O88706 Q6P1H2 Q9R1R1	LIM/homeobox protein Lhx6	LIM/homeobox protein Lhx6.1;	 PF00046;PF00412;	 GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000977;GO:1990837;GO:0048469;GO:0021853;GO:0021895;GO:0021799;GO:0021800;GO:0021884;GO:0021877;GO:0030182;GO:0006357;	  C:nucleus;	  F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:cell maturation; P:cerebral cortex GABAergic interneuron migration; P:cerebral cortex neuron differentiation; P:cerebral cortex radially oriented cell migration; P:cerebral cortex tangential migration; P:forebrain neuron development; P:forebrain neuron fate commitment; P:neuron differentiation; P:regulation of transcription by RNA polymerase II;
XM_040196285.1	chrXIII	17504292	17504292	chrXIII	17495802	17502159	+	XM_040196285.1	path1	O97554	Prostaglandin G/H synthase 1	Cyclooxygenase-1;Prostaglandin H2 synthase 1;Prostaglandin-endoperoxide synthase 1;	 PF03098;PF00008;	 GO:0005789;GO:0051213;GO:0020037;GO:0046872;GO:0004601;GO:0004666;GO:0019371;GO:0006954;GO:0008217;GO:0006979;	  C:endoplasmic reticulum membrane;	  F:dioxygenase activity; F:heme binding; F:metal ion binding; F:peroxidase activity; F:prostaglandin-endoperoxide synthase activity;	  P:cyclooxygenase pathway; P:inflammatory response; P:regulation of blood pressure; P:response to oxidative stress;
XM_040196282.1	chrXIII	17504292	17504292	chrXIII	17502782	17513421	-	XM_040196282.1	path1	D3YXG0 D3Z2Q7	Hemicentin-1 {ECO:0000312|MGI:MGI:2685047}	Fibulin-6 {ECO:0000303|PubMed:24951538};	 PF12662;PF07645;PF07474;PF07679;PF00090;	 GO:0005912;GO:0005604;GO:0005938;GO:0030054;GO:0032154;GO:0062023;GO:0005576;GO:0005509;GO:0007049;GO:0051301;GO:0007157;GO:0007156;GO:0009617;	  C:adherens junction; C:basement membrane; C:cell cortex; C:cell junction; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular region;	  F:calcium ion binding;	  P:cell cycle; P:cell division; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:response to bacterium;
XM_040195754.1	chrXIII	17504292	17504292	chrXIII	17515144	17520268	+	XM_040195754.1	path1	Q10713 B4DKL3 E7ET61 Q16639 Q5SXM9 Q8N513	Mitochondrial-processing peptidase subunit alpha	Alpha-MPP;Inactive zinc metalloprotease alpha {ECO:0000305};P-55;	 PF00675;PF05193;	 GO:0005615;GO:0005743;GO:0005759;GO:0005739;GO:0046872;GO:0006851;GO:0006627;	  C:extracellular space; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;	  F:metal ion binding;	  P:mitochondrial calcium ion transmembrane transport; P:protein processing involved in protein targeting to mitochondrion;
XM_040195752.1	chrXIII	17504292	17504292	chrXIII	17520299	17524700	-	XM_040195752.1	path1	Q9WVR1 A0A0G2K6T4	Phosphatidylinositol polyphosphate 5-phosphatase type IV	5-phosphatase that induces arborization {ECO:0000303|PubMed:10405344};72 kDa inositol polyphosphate 5-phosphatase;Inositol polyphosphate-5-phosphatase E;Phosphatidylinositol 4,5-bisphosphate 5-phosphatase;Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase;	 PF03372;	 GO:0005930;GO:0005929;GO:0005737;GO:0005925;GO:0032580;GO:0000139;GO:0005654;GO:0005634;GO:0005886;GO:0001726;GO:0004445;GO:0016314;GO:0034485;GO:0004439;GO:0106019;GO:0046855;GO:0014067;GO:1903565;GO:0017148;GO:0046856;GO:0046488;	  C:axoneme; C:cilium; C:cytoplasm; C:focal adhesion; C:Golgi cisterna membrane; C:Golgi membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ruffle;	  F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate phosphatase activity;	  P:inositol phosphate dephosphorylation; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein localization to cilium; P:negative regulation of translation; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process;
XM_040196339.1	chrXIII	17672721	17672721	chrXIII	17618839	17651331	-	XM_040196339.1	path1	Q6ZPR4 B2RUK3 Q8C3E7	Potassium channel subfamily T member 1		 PF03493;PF07885;	 GO:0016021;GO:0005886;GO:0005228;GO:0015271;GO:0005267;GO:0006813;	  C:integral component of membrane; C:plasma membrane;	  F:intracellular sodium activated potassium channel activity; F:outward rectifier potassium channel activity; F:potassium channel activity;	  P:potassium ion transport;
XM_040196350.1	chrXIII	17672721	17672721	chrXIII	17664820	17675071	-	XM_040196350.1	path1	Q6DFF6	Kelch-like protein 20		 PF07707;PF00651;PF01344;	 GO:0031463;GO:0005737;GO:0005829;GO:0048471;GO:0016605;GO:0005802;GO:0019964;GO:0004842;GO:0006895;GO:0043066;GO:0043161;GO:1990390;GO:0015031;GO:0016567;	  C:Cul3-RING ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:perinuclear region of cytoplasm; C:PML body; C:trans-Golgi network;	  F:interferon-gamma binding; F:ubiquitin-protein transferase activity;	  P:Golgi to endosome transport; P:negative regulation of apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K33-linked ubiquitination; P:protein transport; P:protein ubiquitination;
XM_040195466.1	chrXIII	17672721	17672721	chrXIII	17687426	17740210	+	XM_040195466.1	path1	A0MSJ1	Collagen alpha-1(XXVII) chain B		 PF01410;PF01391;	 GO:0005581;GO:0031012;GO:0005615;GO:0005201;GO:0046872;GO:0030282;GO:0030198;GO:0048570;GO:0001501;	  C:collagen trimer; C:extracellular matrix; C:extracellular space;	  F:extracellular matrix structural constituent; F:metal ion binding;	  P:bone mineralization; P:extracellular matrix organization; P:notochord morphogenesis; P:skeletal system development;
XM_040197899.1	chrXIV	14976283	14976283	chrXIV	14935203	14977890	-	XM_040197899.1	path1	B0UXH6 A6H8S8	Ras-specific guanine nucleotide-releasing factor RalGPS1	Ral GEF with PH domain and SH3-binding motif 1;RalA exchange factor RalGPS1;	 PF00169;PF00617;	 GO:0005737;GO:0005886;GO:0005085;GO:0007264;	  C:cytoplasm; C:plasma membrane;	  F:guanyl-nucleotide exchange factor activity;	  P:small GTPase mediated signal transduction;
XM_040197901.1	chrXIV	14976285	14976285	chrXIV	14978022	14980871	+	XM_040197901.1	path1	Q8K450 Q0VBE7 Q8C450 Q9CPU8 Q9D522	Sperm-associated antigen 16 protein	Pf20 protein homolog;	 PF00400;	 GO:1990716;GO:0005930;GO:0005737;GO:0005576;GO:0002177;GO:0005634;GO:0036126;GO:0019901;GO:0035082;GO:0097231;GO:0090660;GO:0060271;GO:0060294;GO:0051012;GO:0120197;GO:0007288;	  C:axonemal central apparatus; C:axoneme; C:cytoplasm; C:extracellular region; C:manchette; C:nucleus; C:sperm flagellum;	  F:protein kinase binding;	  P:axoneme assembly; P:cell motility in response to calcium ion; P:cerebrospinal fluid circulation; P:cilium assembly; P:cilium movement involved in cell motility; P:microtubule sliding; P:mucociliary clearance; P:sperm axoneme assembly;
XM_040197921.1	chrXIV	15071770	15071770	chrXIV	15077327	15252623	+	XM_040197921.1	path1	P43146	Netrin receptor DCC	Colorectal cancer suppressor;Immunoglobulin superfamily DCC subclass member 1;Tumor suppressor protein DCC;	 PF00041;PF07679;PF06583;	 GO:0030424;GO:0005829;GO:0099061;GO:0005886;GO:0098685;GO:0005042;GO:0004888;GO:0033564;GO:0006915;GO:0007411;GO:0007409;GO:0033563;GO:0097192;GO:0048671;GO:2000171;GO:1902842;GO:0010977;GO:0001764;GO:0099170;GO:1901214;GO:0021965;	  C:axon; C:cytosol; C:integral component of postsynaptic density membrane; C:plasma membrane; C:Schaffer collateral - CA1 synapse;	  F:netrin receptor activity; F:transmembrane signaling receptor activity;	  P:anterior/posterior axon guidance; P:apoptotic process; P:axon guidance; P:axonogenesis; P:dorsal/ventral axon guidance; P:extrinsic apoptotic signaling pathway in absence of ligand; P:negative regulation of collateral sprouting; P:negative regulation of dendrite development; P:negative regulation of netrin-activated signaling pathway; P:negative regulation of neuron projection development; P:neuron migration; P:postsynaptic modulation of chemical synaptic transmission; P:regulation of neuron death; P:spinal cord ventral commissure morphogenesis;
XM_040200200.1	chrXV	11643350	11643350	chrXV	11639390	11652011	-	XM_040200200.1	path1	Q149N8 Q149N9 Q5VV79 Q68DS5 Q7Z5J5 Q8IVE8 Q8IWQ9 Q8N1S8 Q8NBR7	E3 ubiquitin-protein ligase SHPRH	RING-type E3 ubiquitin transferase SHPRH {ECO:0000305};SNF2, histone-linker, PHD and RING finger domain-containing helicase;	 PF00271;PF00538;PF00176;	 GO:0005654;GO:0000786;GO:0005524;GO:0003677;GO:0004386;GO:0016787;GO:0046872;GO:0070615;GO:0061630;GO:0031625;GO:0004842;GO:0006974;GO:0006281;GO:0006334;GO:0000209;GO:0016567;	  C:nucleoplasm; C:nucleosome;	  F:ATP binding; F:DNA binding; F:helicase activity; F:hydrolase activity; F:metal ion binding; F:nucleosome-dependent ATPase activity; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:ubiquitin-protein transferase activity;	  P:cellular response to DNA damage stimulus; P:DNA repair; P:nucleosome assembly; P:protein polyubiquitination; P:protein ubiquitination;
XM_040200285.1	chrXV	11782254	11782254	chrXV	11776340	11781829	+	XM_040200285.1	path1	P62760 D6W515 P28677 P29103 P42323 Q9UM20	Visinin-like protein 1	Hippocalcin-like protein 3;	 PF00036;PF13499;	 GO:0005829;GO:0016020;GO:0005509;GO:0046676;GO:0045921;GO:0035774;	  C:cytosol; C:membrane;	  F:calcium ion binding;	  P:negative regulation of insulin secretion; P:positive regulation of exocytosis; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus;
XM_040200214.1	chrXV	11782254	11782254	chrXV	11782440	11793388	-	XM_040200214.1	path1	Q6P9I7 Q805A0	Structural maintenance of chromosomes protein 6		 PF02463;	 GO:0000781;GO:0016605;GO:0030915;GO:0005524;GO:0090398;GO:0006281;GO:0000722;	  C:chromosome, telomeric region; C:PML body; C:Smc5-Smc6 complex;	  F:ATP binding;	  P:cellular senescence; P:DNA repair; P:telomere maintenance via recombination;
XM_040200202.1	chrXV	11786369	11786369	chrXV	11793392	11799191	+	XM_040200202.1	path1	F1R237 F1RE34	Tudor domain-containing 6 {ECO:0000305}		 PF00567;	 GO:0033391;GO:0060293;GO:0032019;GO:0043186;GO:0007281;GO:0070925;GO:1903863;GO:1905879;GO:0007283;	  C:chromatoid body; C:germ plasm; C:mitochondrial cloud; C:P granule;	 	  P:germ cell development; P:organelle assembly; P:P granule assembly; P:regulation of oogenesis; P:spermatogenesis;
XM_040200229.1	chrXV	11812932	11812932	chrXV	11800754	11807945	-	XM_040200229.1	path1	Q8IZF5 B4DF15 E9PEV1 Q53TA5 Q6UXT7 Q6UXX3 Q86SL7 Q8IXD8 Q8TDT3	Adhesion G-protein coupled receptor F3	G-protein coupled receptor 113;G-protein coupled receptor PGR23;	 PF00002;PF01825;	 GO:0016021;GO:0004930;GO:0007166;GO:0007186;	  C:integral component of membrane;	  F:G protein-coupled receptor activity;	  P:cell surface receptor signaling pathway; P:G protein-coupled receptor signaling pathway;
XM_040199910.1	chrXV	11812932	11812932	chrXV	11808693	11815863	-	XM_040199910.1	path1	O70247	Sodium-dependent multivitamin transporter	Solute carrier family 5 member 6;	 PF00474;	 GO:0031526;GO:0016021;GO:0005886;GO:0012506;GO:0015225;GO:0015233;GO:0008523;GO:0015293;GO:1905135;GO:0015878;GO:1904200;GO:0015887;GO:0006814;GO:0150104;	  C:brush border membrane; C:integral component of membrane; C:plasma membrane; C:vesicle membrane;	  F:biotin transmembrane transporter activity; F:pantothenate transmembrane transporter activity; F:sodium-dependent multivitamin transmembrane transporter activity; F:symporter activity;	  P:biotin import across plasma membrane; P:biotin transport; P:iodide transmembrane transport; P:pantothenate transmembrane transport; P:sodium ion transport; P:transport across blood-brain barrier;
XM_040199912.1	chrXV	11812932	11812932	chrXV	11817147	11821237	+	XM_040199912.1	path1	Q28HU3 Q501R3	Centromere protein O		 PF09496;	 GO:0000778;GO:0031511;GO:0034508;	  C:condensed nuclear chromosome kinetochore; C:Mis6-Sim4 complex;	 	  P:centromere complex assembly;
XM_040199458.1	chrXV	11812932	11812932	chrXV	11821499	11825238	+	XM_040199458.1	path1	Q53FA7 D6W533 O14679 O14685 Q38G78 Q6JLE7 Q9BWB8	Quinone oxidoreductase PIG3	Tumor protein p53-inducible protein 3;p53-induced gene 3 protein;	 PF08240;PF00107;	 GO:0005829;GO:0070402;GO:0003960;GO:0042803;GO:0048038;GO:0006739;GO:0042981;	  C:cytosol;	  F:NADPH binding; F:NADPH:quinone reductase activity; F:protein homodimerization activity; F:quinone binding;	  P:NADP metabolic process; P:regulation of apoptotic process;
XM_040202364.1	chrXVI	13384292	13384292	chrXVI	13393873	13399018	-	XM_040202364.1	path1	Q5RAL4	Syntaxin-19		 PF00804;	 GO:0005737;GO:0016021;GO:0005886;GO:0005484;GO:0006886;GO:0016192;	  C:cytoplasm; C:integral component of membrane; C:plasma membrane;	  F:SNAP receptor activity;	  P:intracellular protein transport; P:vesicle-mediated transport;
XM_040203812.1	chrXVII	2757133	2757133	chrXVII	2755190	2761610	+	XM_040203812.1	path1	O75911 B2R7F3 Q5VUY3 Q6UY38 Q9BUC8	Short-chain dehydrogenase/reductase 3	DD83.1;Retinal short-chain dehydrogenase/reductase 1;Retinol dehydrogenase 17;Short chain dehydrogenase/reductase family 16C member 1;	 PF00106;	 GO:0005789;GO:0016021;GO:0005811;GO:0042622;GO:0009055;GO:0052650;GO:0000166;GO:0016616;GO:0004745;GO:0060349;GO:0060411;GO:0048387;GO:0003151;GO:0030278;GO:0048385;GO:0001523;GO:0042572;GO:0060021;GO:0007601;	  C:endoplasmic reticulum membrane; C:integral component of membrane; C:lipid droplet; C:photoreceptor outer segment membrane;	  F:electron transfer activity; F:NADP-retinol dehydrogenase activity; F:nucleotide binding; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:retinol dehydrogenase activity;	  P:bone morphogenesis; P:cardiac septum morphogenesis; P:negative regulation of retinoic acid receptor signaling pathway; P:outflow tract morphogenesis; P:regulation of ossification; P:regulation of retinoic acid receptor signaling pathway; P:retinoid metabolic process; P:retinol metabolic process; P:roof of mouth development; P:visual perception;
XM_040204824.1	chrXVII	2850980	2850980	chrXVII	2819043	2913761	-	XM_040204824.1	path1	P54763 A3KG00 A3KG01 A3KG02 A3KG89 A3KG90 Q62213 Q6GTQ7 Q6P5F1 Q9QVY4	Ephrin type-B receptor 2 {ECO:0000305}	Neural kinase;Nuk receptor tyrosine kinase;Tyrosine-protein kinase receptor EPH-3;Tyrosine-protein kinase receptor SEK-3;	 PF14575;PF01404;PF07699;PF00041;PF07714;PF00536;	 GO:0030424;GO:0030425;GO:0098978;GO:0005887;GO:0099055;GO:0099056;GO:0043005;GO:0043025;GO:0005654;GO:0005886;GO:0043235;GO:0045202;GO:0001540;GO:0005524;GO:0008046;GO:0005003;GO:0042802;GO:0004713;GO:0044877;GO:0038023;GO:0005102;GO:0004714;GO:0005005;GO:0001525;GO:0009887;GO:0007411;GO:0007413;GO:0042113;GO:0048593;GO:0000902;GO:0021952;GO:0071679;GO:0022038;GO:0060996;GO:0060997;GO:0048013;GO:0051389;GO:0042472;GO:0007612;GO:0007611;GO:0007275;GO:0050771;GO:0007162;GO:0070373;GO:1904782;GO:0001933;GO:0046580;GO:0106028;GO:0021631;GO:0018108;GO:0016310;GO:0030890;GO:0030335;GO:0010628;GO:0002639;GO:0033674;GO:0048170;GO:1900273;GO:1904783;GO:1903078;GO:0051965;GO:0031915;GO:0032760;GO:0097104;GO:0006468;GO:0050770;GO:0030193;GO:0050878;GO:0048168;GO:0051963;GO:0031290;GO:0060021;GO:0099557;GO:0007169;GO:0001655;	  C:axon; C:dendrite; C:glutamatergic synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:neuron projection; C:neuronal cell body; C:nucleoplasm; C:plasma membrane; C:receptor complex; C:synapse;	  F:amyloid-beta binding; F:ATP binding; F:axon guidance receptor activity; F:ephrin receptor activity; F:identical protein binding; F:protein tyrosine kinase activity; F:protein-containing complex binding; F:signaling receptor activity; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;	  P:angiogenesis; P:animal organ morphogenesis; P:axon guidance; P:axonal fasciculation; P:B cell activation; P:camera-type eye morphogenesis; P:cell morphogenesis; P:central nervous system projection neuron axonogenesis; P:commissural neuron axon guidance; P:corpus callosum development; P:dendritic spine development; P:dendritic spine morphogenesis; P:ephrin receptor signaling pathway; P:inactivation of MAPKK activity; P:inner ear morphogenesis; P:learning; P:learning or memory; P:multicellular organism development; P:negative regulation of axonogenesis; P:negative regulation of cell adhesion; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of NMDA glutamate receptor activity; P:negative regulation of protein phosphorylation; P:negative regulation of Ras protein signal transduction; P:neuron projection retraction; P:optic nerve morphogenesis; P:peptidyl-tyrosine phosphorylation; P:phosphorylation; P:positive regulation of B cell proliferation; P:positive regulation of cell migration; P:positive regulation of gene expression; P:positive regulation of immunoglobulin production; P:positive regulation of kinase activity; P:positive regulation of long-term neuronal synaptic plasticity; P:positive regulation of long-term synaptic potentiation; P:positive regulation of NMDA glutamate receptor activity; P:positive regulation of protein localization to plasma membrane; P:positive regulation of synapse assembly; P:positive regulation of synaptic plasticity; P:positive regulation of tumor necrosis factor production; P:postsynaptic membrane assembly; P:protein phosphorylation; P:regulation of axonogenesis; P:regulation of blood coagulation; P:regulation of body fluid levels; P:regulation of neuronal synaptic plasticity; P:regulation of synapse assembly; P:retinal ganglion cell axon guidance; P:roof of mouth development; P:trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:urogenital system development;
XM_040203559.1	chrXVII	9308920	9308920	chrXVII	9289012	9329997	+	XM_040203559.1	path1	O43295 Q8IX13 Q8IZV8	SLIT-ROBO Rho GTPase-activating protein 3	Mental disorder-associated GAP;Rho GTPase-activating protein 14;WAVE-associated Rac GTPase-activating protein;	 PF00611;PF00620;PF00018;	 GO:0005737;GO:0005829;GO:0005096;GO:0030336;GO:0043547;GO:0051056;GO:0007165;	  C:cytoplasm; C:cytosol;	  F:GTPase activator activity;	  P:negative regulation of cell migration; P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction;
